Literature DB >> 20723753

The Immunoproteasome Cleans up after Inflammation.

Sjoerd van Deventer1, Jacques Neefjes.   

Abstract

Immune cells and cells activated by the inflammatory cytokine interferon express variant proteasomes called immunoproteasomes that are characterized by unique catalytic subunits. Seifert et al. (2010) now show in mouse models of inflammatory disease that immunoproteasomes help prevent the accumulation of harmful protein aggregates. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 20723753     DOI： 10.1016/j.cell.2010.08.002

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  17 in total

1.  Structural defects in the regulatory particle-core particle interface of the proteasome induce a novel proteasome stress response.

Authors:  Soyeon Park; Woong Kim; Geng Tian; Steven P Gygi; Daniel Finley
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

Review 2.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

3.  Transient focal cerebral ischemia upregulates immunoproteasomal subunits.

Authors:  Lanhai Lü; Hongmin Wang
Journal:  Cell Mol Neurobiol       Date:  2012-05-22       Impact factor: 5.046

4.  Anti-viral immune responses in a primitive lung: characterization and expression analysis of interferon-inducible immunoproteasome subunits LMP2, LMP7 and MECL-1 in a sarcopterygian fish, the Nigerian spotted lungfish (Protopterus dolloi).

Authors:  Luca Tacchi; Milind Misra; Irene Salinas
Journal:  Dev Comp Immunol       Date:  2013-08-06       Impact factor: 3.636

5.  Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2.

Authors:  Haiyan Sun; Choon-myung Lee; Shweta Tripathi; Kyung-Bo Kim; Edward T Morgan
Journal:  Biochem J       Date:  2012-08-01       Impact factor: 3.857

6.  The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Marc R Wilkins; Chew Gee Tan; Jose A Burgos-Portugal; Mark J Raftery; Andrew S Day; Daniel A Lemberg; Hazel Mitchell
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

7.  ABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs.

Authors:  Paola Nicoletti; Mukesh Bansal; Celine Lefebvre; Paolo Guarnieri; Yufeng Shen; Itsik Pe'er; Andrea Califano; Aris Floratos
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke.

Authors:  X Chen; X Zhang; Y Wang; H Lei; H Su; J Zeng; Z Pei; R Huang
Journal:  Cell Death Dis       Date:  2015-01-29       Impact factor: 8.469

9.  Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.

Authors:  A Minelli; C Magri; A Barbon; C Bonvicini; M Segala; C Congiu; S Bignotti; E Milanesi; L Trabucchi; N Cattane; M Bortolomasi; M Gennarelli
Journal:  Transl Psychiatry       Date:  2015-12-01       Impact factor: 6.222

10.  Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteins.

Authors:  James A Nathan; Valentina Spinnenhirn; Gunter Schmidtke; Michael Basler; Marcus Groettrup; Alfred L Goldberg
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.